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INTRODUCTION
Thyroid carcinoma is the most common type of endocrine 
malignancy, and its incidence is rapidly increasing.1,2 Over 90% 
of all thyroid carcinomas exhibit a relatively indolent clinical 
course, with excellent prognosis.1,3 In contrast, cervical lymph 
node metastasis has been observed in 30% to 90% of patients 
with papillary thyroid cancer (PTC) and has been shown to be 
closely associated with persistent and recurrent disease.1,4-9 Most 
metastatic sites in patients with PTC are located in central com-
partment lymph nodes,10,11 and central lymph node dissection 
has been found to reduce loco-regional recurrence and improve 
disease-free survival in patients with PTC.11,12
The anatomical borders of the central compartment lymph 
nodes include the hyoid bone superiorly, the innominate artery 
inferiorly, and the common carotid arteries bilaterally. A con-
sensus statement has listed the prelaryngeal (Delphian), pre-
tracheal, and paratracheal nodal basins bilaterally as the central 
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Purpose: Although guidelines indicate that routine dissection of the central lymph nodes in patients with thyroid carcinoma 
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cervical oesophagus and posterior to the former, RPELN dissection is often omitted due to high risk of injuries to the recurrent la-
ryngeal nerve and the right inferior parathyroid gland.
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total thyroidectomy with central lymph node dissection, including the RPELNs, between January 1, 2009 and December 31, 2013 
at the Thyroid Cancer Center of Yonsei University College of Medicine, Seoul, Korea. 
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total of 95.9% of patients with RPELN metastasis had central node (except right para-oesophageal lymph node) metastasis, and 
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14.3%, p<0.001). Forty-one patients underwent mediastinal dissection, with 11 patients confirmed as having mediastinal lymph 
node metastasis with RPELN metastasis on pathological examination.
Conclusion: RPELN metastasis is significantly associated with lateral neck and mediastinal lymph node metastasis.
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compartment lymph node group. Therapeutic and prophylac-
tic central lymph node dissection requires the removal of all 
three lymph node groups at the minimum.4 
The lymph node located between the right recurrent laryn-
geal nerve and the cervical oesophagus is called the right para-
oesophageal lymph node (RPELN). Due to its location, the 
RPELN is considered one of the central compartment lymph 
nodes. Although it has been recommended that routine cen-
tral lymph node dissection should include the RPELN posteri-
or to the right recurrent laryngeal nerve,13 dissection of the 
RPELN is often omitted due to high risk of injuries to the recur-
rent laryngeal nerve and the right inferior parathyroid gland 
(Fig. 1). To determine the necessity of RPELN dissection, we 
assessed the clinical significance of RPELN metastasis and the 
factors affecting it.
MATERIALS AND METHODS
We retrospectively reviewed our database to identify all pa-
tients who were diagnosed with thyroid carcinoma and un-
derwent total thyroidectomy with central lymph node dissec-
tion, including RPELN dissection, between January 1, 2009, 
and December 31, 2013 at the Thyroid Cancer Center, Gang-
nam Severance Hospital, Yonsei University College of Medi-
cine, Seoul, Korea. Dissection of the central nodes was per-
formed routinely. Lateral neck metastasis was diagnosed 
based on preoperative fine-needle aspiration cytology or in-
traoperative frozen sectioning and sampling of suspicious 
lymph nodes, and patients with lateral neck metastasis un-
derwent lateral neck dissection. Mediastinal dissection was 
performed if mediastinal metastasis was confirmed after the 
intraoperative frozen sectioning of suspicious nodes that had 
been evaluated by preoperative radiologic findings. 
Postoperative histopathologic results were confirmed by a 
single specialized endocrine pathologist (S. W. Hong); the pa-
tients were then divided into two groups according to whether 
the histopathologic records indicated pathologically proven 
RPELN metastasis. The clinicopathological characteristics of 
the two groups were compared, including sex, age, tumour 
size, location, multiplicity, bilateral involvement, extrathyroi-
dal extension, and central, lateral, and mediastinal lymph 
node invasion. All statistical analyses were performed using 
the Statistical Package for Social Science version 20.0 for Win-
dows (SPSS Inc., Chicago, IL, USA). Data were compared us-
ing Student’s t-test, a chi-square test, and Fisher’s exact test as 
appropriate. Multiple logistic regression analysis was used to 
assess the statistical significance of the associations between 
RPELN metastasis and clinicopathologic factors. Odds ratios 
(ORs) with 95% relative confidence intervals were calculated 
to determine the relevance of all potential predictors. A p val-
ue<0.05 was considered statistically significant.
This study was approved by the Institutional Review Board 
of Gangnam Severance Hospital, Yonsei University College of 
Medicine, which waived the requirements for patient approv-
al and informed consent due to the retrospective nature of 
this study.
RESULTS
Of the 5556 patients who underwent RPELN dissection, all 
patients had PTC. Table 1 shows the demographic and patho-
logic characteristics of these patients. Final pathology reports 
indicated that 148 (2.7%) patients were diagnosed as positive 
(RPELN+) and 5408 (97.3%) as negative (RPELN-) for RPELN. 
Mean tumour size was larger in the RPELN+ group than in the 
RPELN- group (p<0.001). Mean age was younger in the RPELN+ 
group than in the RPELN- group (43.4±11.6 years vs. 46.2±11.5 
years; p=0.003). Patients older than 45 years were dominant in 
the RPELN- group (RPELN+: 40.5%; RPELN-: 53.7%; p=0.002). 
Of the 148 patients in the RPELN+ group, 91 (61.5%) had 
primary tumours greater than 1 cm in size (p=0.008). Extra-
thyroidal extension by the primary tumour (81.8%; p<0.001) 
and multifocality (52.7%; p=0.001) were more common in the 
RPELN+ group than in the RPELN- group.
Central node metastases, excluding RPELNs metastasis 
(95.9% vs. 44.2%; p<0.001) and lateral neck node metastasis 
(63.5% vs. 14.3%; p<0.001), were significantly more frequent 
in the RPELN+ group than in the RPELN- group (Table 2).
Forty-one patients underwent mediastinal dissection, with 
all confirmed as having mediastinal lymph node metastasis 
on pathological examination; 11 (7.4%) of these patients were 
in the RPELN+ group (7.4% vs. 0.6%; p<0.001), indicating that 
RPELN is closely associated with mediastinal lymph node 
metastasis (Table 2).
The results of the multivariable logistic regression analysis 
are shown in Table 3. Following adjustment for other predic-
Fig. 1. Location of right para-oesophageal lymph nodes. IJV, internal 
jugular vein; CCA, common carotid artery.
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tors, tumour size, bilateral involvement, and extrathyroidal ex-
tension were no longer significantly predictive of RPELN me-
tastasis. However, central node metastasis, excluding RPELN 
metastasis (OR=14.715; p<0.001) and lateral neck node (OR= 
4.383; p=0.016) metastasis, were significantly predictive of 
RPELN metastasis. Other results are shown in Table 4. In a mul-
tivariate analysis of factors associated with mediastinal metas-
tasis, RPELN metastasis was significantly predictive of medi-
astinal metastasis.
Twenty-seven patients experienced postoperative hoarseness, 
24 of whom had undergone shaving-off procedures for recur-
rent laryngeal nerve invasion due to thyroid cancer. Overall, 64 
patients (1.15%) were diagnosed with permanent hypoparathy-
roidism, defined as an s-PTH concentration <10.0 pg/mL, and 
persistent hypocalcaemic symptoms of a tingling sensation and 
numbness requiring oral calcium supplements at 3 months. 








Male/female (%) 52/96 (35.1/64.9) 1119/4289 (20.7/79.3) <0.001
Age
Mean age, yrs 43.4±11.6 46.2±11.5 0.003
≥45 (%) 60 (40.5) 2903 (53.7) 0.002
Primary tumor
Mean tumour size (cm) 1.49±1.07 0.99±0.69 <0.001
>1 cm (%) 91 (61.5) 1791 (33.1) <0.001
Thyroiditis (%) 53 (35.8) 2090 (38.6) 0.549
Extrathyroidal extension (%) 121 (81.8) 3338 (61.7) <0.001
Multifocality (%) 79 (52.7) 2072 (38.3) 0.001
Bilaterality (%) 52 (35.1) 1381 (25.5) 0.01
Psammomatous calcification (%) 97 (65.5) 2110 (39.0) <0.001
RPELN, right para-oesophageal lymph node; RPELN+, with RPELN metastasis; RPELN-, without RPELN metastasis.
Values are expressed as the number and percent or the mean±SD.







Central node metastasis (excluding RPELN metastasis) (%) 142 (95.9) 2390 (44.2) <0.001
Lateral neck node metastasis (%) 94 (63.5) 773 (14.3) <0.001
Mediastinal metastasis (%) 11 (7.4) 30 (0.6) <0.001
RPELN, right para-oesophageal lymph node; RPELN+, with RPELN metastasis; RPELN-, without RPELN metastasis.
Table 3. Multivariate Analysis of Factors Associated with RPELN Metastasis 
Variables Odds ratio (95% CI) p value
Gender (male) 1.315 (0.917–1.886) 0.136
Age ≥45 1.405 (0.735–1.485) 0.808
Primary tumour
Tumour size (>1 cm vs. ≤1 cm) 1.406 (0.974–2.031) 0.069
Extrathyroidal extension 1.274 (0.816–1.990) 0.286
Psammomatous calcification 1.373 (0.954–1.976) 0.088
Multifocality 1.376 (0.852–2.222) 0.192
Bilaterality 0.936 (0.566–1.546) 0.795
Nodal status
Central node metastasis (excluding RPELN metastasis) 14.715 (6.363–34.032) <0.001
Lateral node metastasis 4.383 (3.016–6.370) <0.001
RPELN, right para-oesophageal lymph node; CI, confidence interval.
1635http://dx.doi.org/10.3349/ymj.2015.56.6.1632
Hojin Chang, et al.
DISCUSSION
Cervical lymph node metastasis is a factor associated with 
poor prognosis in patients with thyroid carcinoma.5,14-16 Extra-
nodal invasion in PTC was found to be strongly associated 
with later development of distant metastasis and with a signif-
icantly higher mortality rate.14 Moreover, a population-based, 
nested case-control study demonstrated that lymph node me-
tastasis increases mortality rates in patients with differentiated 
thyroid carcinoma.16 Other factors independently associated 
with persistent disease and recurrence are a tumour size >3 
cm, extra-capsular extension, and the locations of metastatic 
lymph nodes,5,15 with central compartment lymph nodes being 
the most frequently involved site.4-6,15-17 Thus, complete surgi-
cal removal of lymph nodes in the central compartment dur-
ing thyroid cancer surgery is needed to reduce disease persis-
tence and recurrence as well as mortality.11 
Although RPELNs are located within the central compart-
ment, they are frequently not removed during thyroid cancer 
surgery due to the high risk of injuries to the right recurrent 
laryngeal nerve and parathyroid gland. In investigating the 
clinicopathologic features of PTC patients with RPELN metas-
tasis, we found that pathologically confirmed RPELN metas-
tasis was associated with a larger tumour size and extrathyroi-
dal extension. Additionally, both central and lateral neck node 
metastases showed significant correlations with RPELN me-
tastasis on both univariate and multivariate analyses, findings 
that were consistent with previous results.18,19
Although mediastinal metastasis is fairly uncommon in dif-
ferentiated thyroid carcinoma, it may result in a devastating 
clinical course by directly invading mediastinal organs.4,20,21 
Several studies have assessed the possible risk factors related 
to mediastinal metastasis in thyroid carcinoma. For example, 
patients with central neck metastasis, a tumour size >1.5 cm, 
or lymphovascular invasion were found to have a significantly 
higher rate of lymph node metastasis in the anterior superior 
mediastinum and the tracheo-oesophageal grooves, extending 
from the suprasternal notch to the innominate artery,22 and 
poor tumour differentiation and distant metastases were found 
to be predictive of mediastinal metastasis.23 An evaluation of 
the pattern of nodal metastasis in thyroid carcinoma showed 
that a greater number of metastatic lymph nodes occurred in 
patients with distant metastasis.4 Lymph nodes in the lower 
third of the neck may function as a bridge between the cervical 
and mediastinal lymphatic chains.24 Indeed, we found that pa-
tients pathologically confirmed to have mediastinal metastasis 
were more likely to exhibit RPELN metastasis than patients 
without RPELN metastasis were likely to have mediastinal me-
tastasis. These findings suggest that RPELNs may be the route 
from mediastinal lymph nodes to lateral neck node metastasis.
In addition to the close relationship between RPELN metas-
tasis with lateral neck involvement,22 we found that patients 
with RPELN metastasis demonstrated a high rate of central 
neck node metastasis. These findings suggest that the presence 
of RPELN metastasis may be associated with a more aggressive 
disease course and strongly indicate that RPELNs should be in-
cluded in routine central lymph nodes dissection (CLND). More-
over, a careful work-up of the lateral neck compartment should 
be considered in patients with RPELN metastasis. Future stud-
ies should assess the association between an aggressive disease 
pattern and RPELN metastasis. 
The extent of surgical management in patients with thyroid 
cancer should include considerations of postoperative compli-
cations and morbidity. Extensive lymph node dissection may 
increase morbidity while not benefiting surgical outcomes and 
the survival rate.8,25,26 Although 27 of our patients experienced 
postoperative hoarseness, this could not be considered a direct 
result of RPELN dissection, as 24 of these patients underwent 
shaving-off procedures due to tumour invasion of the right re-
current laryngeal nerve. The incidence of permanent hypo-
parathyroidism was 1.15%, similar to previous studies.27,28
Several studies on morbidity following reoperation of the 
central compartment for recurrent or persistent thyroid cancer 
suggest that reoperation can be challenging and lead to high 
rates of complications, such as permanent recurrent laryngeal 
nerve palsy and hypoparathyroidism.29-31 Appropriate determi-
Table 4. Multivariate Analysis of Factors Associated with Mediastinal Metastasis
Variables Odds ratio (95% CI) p value
Gender (male) 2.774 (1.445–5.324) 0.002
Primary tumor
Tumour size (>1 cm vs. ≤1 cm) 5.594 (1.929–16.223) 0.002
Extrathyroidal extension 0.997 (0.370–2.684) 0.994
Psammomatous calcification 0.903 (0.451–1.808) 0.773
Multifocality 1.525 (0.595–3.910) 0.38
Bilaterality 1.109 (0.439–2.800) 0.827
Nodal status
Central node metastasis (except RPELN metastasis) 1.321 (0.448–3.894) 0.614
RPELN metastasis 2.388 (1.111–5.131) 0.026
RPELN, right para-oesophageal lymph node.
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6. Pereira JA, Jimeno J, Miquel J, Iglesias M, Munné A, Sancho JJ, et 
al. Nodal yield, morbidity, and recurrence after central neck dis-
section for papillary thyroid carcinoma. Surgery 2005;138:1095-
100.
7. White ML, Gauger PG, Doherty GM. Central lymph node dissec-
tion in differentiated thyroid cancer. World J Surg 2007;31:895-
904.
8. Roh JL, Park JY, Park CI. Total thyroidectomy plus neck dissection 
in differentiated papillary thyroid carcinoma patients: pattern of 
nodal metastasis, morbidity, recurrence, and postoperative levels 
of serum parathyroid hormone. Ann Surg 2007;245:604-10.
9. Zhang L, Wei WJ, Ji QH, Zhu YX, Wang ZY, Wang Y, et al. Risk fac-
tors for neck nodal metastasis in papillary thyroid microcarcino-
ma: a study of 1066 patients. J Clin Endocrinol Metab 2012;97: 
1250-7. 
10. Robbins KT, Clayman G, Levine PA, Medina J, Sessions R, Shaha 
A, et al. Neck dissection classification update: revisions proposed 
by the American Head and Neck Society and the American Acad-
emy of Otolaryngology-Head and Neck Surgery. Arch Otolaryn-
gol Head Neck Surg 2002;128:751-8. 
11. American Thyroid Association Surgery Working Group; American 
Association of Endocrine Surgeons; American Academy of Oto-
laryngology-Head and Neck Surgery; American Head and Neck 
Society, Carty SE, Cooper DS, et al. Consensus statement on the 
terminology and classification of central neck dissection for thy-
roid cancer. Thyroid 2009;19:1153-8. 
12. Wang TS, Evans DB, Fareau GG, Carroll T, Yen TW. Effect of pro-
phylactic central compartment neck dissection on serum thyro-
globulin and recommendations for adjuvant radioactive iodine in 
patients with differentiated thyroid cancer. Ann Surg Oncol 2012; 
19:4217-22. 
13. Grodski S, Cornford L, Sywak M, Sidhu S, Delbridge L. Routine 
level VI lymph node dissection for papillary thyroid cancer: surgi-
cal technique. ANZ J Surg 2007;77:203-8.
14. Yamashita H, Noguchi S, Murakami N, Kawamoto H, Watanabe S. 
Extracapsular invasion of lymph node metastasis is an indicator 
of distant metastasis and poor prognosis in patients with thyroid 
papillary carcinoma. Cancer 1997;80:2268-72.
15. Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. A novel classifica-
tion system for patients with PTC: addition of the new variables of 
large (3 cm or greater) nodal metastases and reclassification dur-
ing the follow-up period. Surgery 2004;135:139-48.
16. Lundgren CI, Hall P, Dickman PW, Zedenius J. Clinically signifi-
cant prognostic factors for differentiated thyroid carcinoma: a 
population-based, nested case-control study. Cancer 2006;106: 
524-31.
17. Gemsenjäger E, Perren A, Seifert B, Schüler G, Schweizer I, Heitz 
PU. Lymph node surgery in papillary thyroid carcinoma. J Am 
Coll Surg 2003;197:182-90.
18. Kim YS, Park WC. Clinical predictors of right upper paraesopha-
geal lymph node metastasis from papillary thyroid carcinoma. 
World J Surg Oncol 2012;10:164.
19. Bae SY, Yang JH, Choi MY, Choe JH, Kim JH, Kim JS. Right parae-
sophageal lymph node dissection in papillary thyroid carcinoma. 
Ann Surg Oncol 2012;19:996-1000.
20. Machens A, Hinze R, Lautenschläger C, Thomusch O, Dralle H. 
Thyroid carcinoma invading the cervicovisceral axis: routes of in-
vasion and clinical implications. Surgery 2001;129:23-8.
21. Honings J, Stephen AE, Marres HA, Gaissert HA. The manage-
ment of thyroid carcinoma invading the larynx or trachea. Laryn-
nation of the extent of primary surgery is therefore needed to 
reduce locoregional recurrence and persistent disease rates in 
patients with PTC. Postoperative morbidity rates can also be re-
duced by meticulous surgical techniques and competency in 
surgical skills. 
This study had several limitations. First, the small sample size 
may be inadequate to draw conclusions on the association be-
tween RPELN and mediastinal metastasis. However, due to the 
rarity of mediastinal metastasis in patients with differentiated 
thyroid carcinoma, our findings may indicate a route between 
the cervical and mediastinal lymphatic channels. Second, only 
RPELNs in the central compartment group were considered. 
Recently, the prelaryngeal (Delphian) nodes were shown to be 
associated with extra-thyroidal tumour extension and an in-
creased incidence of central and lateral neck metastasis,32 sug-
gesting that central compartment lymph node groups other 
than RPELNs may be associated with lateral or mediastinal me-
tastasis. Further studies are needed to investigate the correla-
tions between different lymph node groups in the central com-
partment and lateral or mediastinal metastasis. 
This study has shown that RPELN metastasis was significant-
ly associated with lateral and mediastinal lymph nodes metas-
tasis. RPELN metastasis may be associated with tumour aggres-
siveness and poor prognosis in patients with thyroid cancer. 
Patients with suspected RPELN metastasis should undergo 
complete node dissection, and those with confirmed RPELN 
metastasis should be evaluated for lateral neck and mediastinal 
lymph node metastasis.
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